In ccRCC, IGF2BP3 was found to stabilize a lncRNA called cyclin-dependent kinase inhibitor 2B antisense 1 (CDKN2B-AS1). The gene discussed is IGF2BP3; the disease is nonpapillary renal cell carcinoma.